Dihydroergotamine nasal and Insulin Aspart Injection
Determining the interaction of Dihydroergotamine nasal and Insulin Aspart Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Insulin Aspart Protamine and Insulin Aspart
- Dihydroergotamine nasal-Insulin aspart protamine and insulin aspart Subcutaneous
- Dihydroergotamine nasal-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Dihydroergotamine nasal-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Dihydroergotamine nasal-Insulin Aspart Protamine Injection
- Dihydroergotamine nasal-Insulin aspart, recombinant Subcutaneous
- Insulin Aspart Injection-Dihydroergotamine Nasal Spray
- Insulin Aspart Injection-Dilacor XR
- Insulin Aspart Injection-Dilantin
- Insulin Aspart Injection-Dilantin Infatabs
- Insulin Aspart Injection-Dilantin injection
- Insulin Aspart Injection-Dilantin Kapseals